4 articles Tag Food and Drug Administration

National Childhood Cancer Awareness; Guest Post for Addison Cox

National Childhood Cancer Awareness; Guest Post for Addison Cox

“Addison has some moles on her scalp and they turned out to be melanoma. I feel like I am living a nightmare!” Not exactly the words I ever expected to hear from my long-time friend, Briana Cox, in September of 2011. Melanoma? You mean skin cancer? In an infant?! How on earth does that happen? Addison was a mere three months old when the Cox family’s world was turned upside down…for the second time in …

Continue reading →

Phoenix Hospital Raises Awareness About Addison’s Battle with Melanoma

Phoenix Hospital Raises Awareness About Addison’s Battle with Melanoma

This past May we donated “My First Skinz” Baby swim shirts to the Phoenix Hospital in Phoenix, Arizona in honor of National Skin Cancer Awareness month. The same hospital where one-year-old Addison Cox is being treated for Stage 4 Metastasized Malignant Melanoma.  Her mother Brianna Cox was also diagnosed with Stage 4 Melanoma and succumbed to the disease on February 12, 2012. Since her passing doctors, community and family have been trying to make sense of how …

Continue reading →

FDA Releases New Sunscreen Regulations

FDA Releases New Sunscreen Regulations

Yesterday the U.S. FDA, Food and Drug Administration, released its new sunscreen regulations after 33 years of deliberation. They announced “that sunscreen products meeting modern standards for effectiveness may be labeled with new information to help consumers find products that, when used with other sun protection measures, reduce the risk of skin cancer and early skin aging, as well as help prevent sunburn.” You can access the full press release here. These new regulations will become …

Continue reading →

FDA Approves Yervoy

FDA Approves Yervoy

For the first time in thirteen years the Federal Drug Administration approved a new drug, Yervoy, that has been shown to extend the survival rate in patients with late-stage melanoma!  Yervoy, also known as ipilimumab was developed by Bristol-Myers Squibb. The “yes” was given on March 25, 2011 after the results of  an international study of 676 end-stage melanoma patients was received. The study showed that Yervoy increased the survival rate of melanoma patients from six months to ten months. …

Continue reading →